| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.06 |